Thomas Finnerty
Overview
Thomas Finnerty received an average of $966K in total compensation, including $287K in salary, at Anika Therapeutics from 2017 to 2021.
Source: SEC filings on April 27, 2022, April 30, 2021, and April 25, 2019.
Related executives
We found 13 more executives who work or worked at Anika Therapeutics.
Cheryl Blanchard
Anika Therapeutics
Chief Executive Officer
Michael Levitz
Anika Therapeutics
Chief Financial Officer
David Colleran
Anika Therapeutics
General Counsel
James Loerop
Anika Therapeutics
EVP, Business Development and Strategic Planning
Sylvia Cheung
Anika Therapeutics
Chief Financial Officer
Joseph Darling
Anika Therapeutics
Chief Executive Officer
Charles Sherwood
Anika Therapeutics
Chief Executive Officer
Edward Ahn
Anika Therapeutics